FP
COLL icon

Factorial Partners’s Collegium Pharmaceutical COLL Stock Holding History

Factorial Partners’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,500
Closed -$295K – 97
2022
Q1 		$295K Sell
14,500
-18,800
-56% -$355K 0.2% 85
2021
Q4 		$622K Buy
+33,300
New +$649K 0.41% 74

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Factorial Partners's COLL Position: Q2 2022 in Review

Factorial Partners sold out of Collegium Pharmaceutical (COLL) in Q2 2022, closing a stake of 14,500 shares — an estimated $295K sold.

Factorial Partners first reported a position in COLL in Q4 2021 and held it in 2 quarters. The position peaked at $622K in Q4 2021. 157 funds tracked by Wall St. Rank hold COLL as of Q2 2022.

  • Factorial Partners reported no remaining Collegium Pharmaceutical position as of Q2 2022 after selling out during the quarter.
  • Factorial Partners sold 14,500 Collegium Pharmaceutical shares in Q2 2022, an estimated $295K.
  • Factorial Partners first reported a position in Collegium Pharmaceutical in Q4 2021 and held it in 2 quarters.
  • Factorial Partners's Collegium Pharmaceutical position peaked at $622K in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2022.

Based on Factorial Partners's 13F filing for Q2 2022, filed 3 Aug 2022.